The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Mild Cognitive Impairment: Ten Years Later
Open accessAbstract
In the past 10 years, there has been a virtual explosion in the literature concerning the construct of mild cognitive impairment. The interest in this topic demonstrates the increasing emphasis on the identification of the earliest features of cognitive disorders such as Alzheimer disease and other dementias. Mild cognitive impairment represents the earliest clinical features of these conditions and, hence, has become a focus of clinical, epidemiologic, neuroimaging, biomarker, neuropathological, disease mechanism, and clinical trials research. This review summarizes the progress that has been made while also recognizing the challenges that remain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Any interval between last clinical evaluation and autopsy creates a potential for misclassification, especially since progression to dementia typically seems to be preceded by a prodrome.33”
From Ecology of the Aging Human Brain (2011) · cites this paper as [33]
Experimental — accuracy not yet measuredIn the citing paper
“Mild neurocognitive disorder is a new addition to the DSM nomenclature, previously subsumed by the nonspecific category of 'cognitive disorder not otherwise specified, ' and represents a new framework for the commonly used diagnosis of MCI. 12”
From Classifying neurocognitive disorders: the DSM-5 approach (2014) · cites this paper as [12]
In the citing paper
“The Mayo Criteria correspond best to what is referred to as amnestic MCI in the IWG Criteria, with the main objective of the diagnosis being the identification of AD at the predementia stage.12”
From Classifying neurocognitive disorders: the DSM-5 approach (2014) · cites this paper as [12]
In the citing paper
“These memory changes related to higher or increased social isolation are similar to the rates (12%–30% decline in 2 years) found among older people with progressive memory decline (Cloutier, Chertkow, Kergoat, Gauthier, & Belleville, 2015) and mild cognitive impairment (Petersen et al., 2009) prior to dementia, compared with 2%–4% biannual decline in normal aging.”
From Social isolation and memory decline in later-life (2020) · cites this paper as Petersen et al., 2009
In the citing paper
“Thus, AMCI is considered a high risk group for dementia [6] and has become a common target for secondary prevention.”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [6]
In the citing paper
“The natural history of AD starts slowly in late middle age with mild memory deficits that progress to amnestic mild cognitive impairment (AMCI) [6], which in turn progresses to dementia [7].”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Self-citationMild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Self-citationWinblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Self-citationCurrent concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Self-citationImaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Gauthier, S. G., Reisberg, ., Zaudig, M., Petersen, R. C., Ritchie, K. A., Broich, K., Belleville, S., Brodaty, H., Bennett, D. A., Chertkow, H. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 4,094
Self-citationAlzheimer's Disease Neuroimaging Initiative (ADNI)
Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cb3e25 · Cited by 2,572
Self-citationCerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Self-citationPetersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001) · Neurology · doi:10.1212/wnl.56.9.1133 · Cited by 2,065
Self-citationVitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Self-citationHansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404
Self-citationCSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Mattsson, N. (2009) · JAMA · doi:10.1001/jama.2009.1064 · Cited by 1,176
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Self-citationJack, C. R., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., Knopman, D. S., Boeve, B. F., Klunk, W. E., Mathis, C. A., et al. (2008) · Brain · doi:10.1093/brain/awm336 · Cited by 958
Self-citationPrevalence of Cognitive Impairment without Dementia in the United States
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-6-200803180-00005 · Cited by 946
Classification criteria for mild cognitive impairment
Ritchie, K. A., Artéro, S., & Touchon, J. (2001) · Neurology · doi:10.1212/wnl.56.1.37 · Cited by 831
Roberts, R. O., Geda, Y. E., Knopman, D. S., Cha, R. H., Pankratz, V. S., Boeve, B. F., Ivnik, R. J., Tangalos, E. G., Petersen, R. C., & Rocca, W. A. (2008) · Neuroepidemiology · doi:10.1159/000115751 · Cited by 797
Self-citationPetersen, R. C. (1995) · JAMA · doi:10.1001/jama.1995.03520400044042 · Cited by 783
Self-citationMild cognitive impairment, amnestic type
Ganguli, M., Dodge, H. H., Shen, C., & DeKosky, S. T. (2004) · Neurology · doi:10.1212/01.wnl.0000132523.27540.81 · Cited by 674
Incidence and outcome of mild cognitive impairment in a population-based prospective cohort
Larrieu, S., Letenneur, L., Orgogozo, J., Fabrigoule, C., Amieva, H., Carret, N. L., Barberger‐Gateau, P., & Dartigues, J. (2002) · Neurology · doi:10.1212/01.wnl.0000034176.07159.f8 · Cited by 663
Frequency and course of mild cognitive impairment in a multiethnic community
Manly, J. J., Tang, M., Schupf, N., Stern, Y., Vonsattel, J., & Mayeux, R. P. (2008) · Annals of Neurology · doi:10.1002/ana.21326 · Cited by 619
Lopez, O. L., Jagust, W. J., DeKosky, S. T., Becker, J. T., Fitzpatrick, A., Dulberg, C., Breitner, J., Lyketsos, C., Jones, B., Kawas, C., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.10.1385 · Cited by 618
Neuropathologic Features of Amnestic Mild Cognitive Impairment
Petersen, R. C., Parisi, J. E., Dickson, D. W., Johnson, K. A., Knopman, D. S., Boeve, B. F., Jicha, G. A., Ivnik, R. J., Smith, G. E., Tangalos, E. G., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.665 · Cited by 616
Self-citationProgression of Mild Cognitive Impairment to Dementia in Clinic- vs Community-Based Cohorts
Farias, S. T., Mungas, D., Reed, B., Harvey, D. J., & DeCarli, C. S. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.106 · Cited by 615
Neurofibrillary Tangles, Amyloid, and Memory in Aging and Mild Cognitive Impairment
Guillozet-Bongaarts, A. L., Weıntraub, S., Mash, D. C., & Mesulam, M. M. (2003) · Archives of Neurology · doi:10.1001/archneur.60.5.729 · Cited by 590
Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment
DeCarli, C. S. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00262-x · Cited by 586
Mild cognitive impairment: Long-term course of four clinical subtypes
Busse, A., Hensel, A., Gühne, U., Angermeyer, M. C., & Riedel-Heller, S. G. (2006) · Neurology · doi:10.1212/01.wnl.0000249117.23318.e1 · Cited by 561
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions
Bennett, D. A., Schneider, J. A., Bienias, J. L., Evans, D. A., & Wilson, R. S. (2005) · Neurology · doi:10.1212/01.wnl.0000152982.47274.9e · Cited by 537
Vascular risk factors, incidence of MCI, and rates of progression to dementia
Solfrizzi, V., Panza, F., Colacicco, A. M., D’Introno, A., Capurso, C., Torres, F., Grigoletto, F., Maggi, S., Del Parigi, A., Reiman, E. M., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144281.38555.e3 · Cited by 530
Conversion from subtypes of mild cognitive impairment to Alzheimer dementia
Fischer, P., Jungwirth, S., Zehetmayer, S., Weissgram, S., Hoenigschnabl, S., Gelpi, E., Krampla, W., & Tragl, K. H. (2007) · Neurology · doi:10.1212/01.wnl.0000252358.03285.9d · Cited by 471
Neuropathologic Substrate of Mild Cognitive Impairment
Markesbery, W. R., Schmitt, F. A., Kryscio, R. J., Davis, D. G., Smith, C. D., & Wekstein, D. R. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.38 · Cited by 460
Relationships between biomarkers in aging and dementia
Jagust, W. J., Landau, S. M., Shaw, L. M., Trojanowski, J. Q., Koeppe, R. A., Reiman, E. M., Foster, N. L., Petersen, R. C., Weiner, M. W., Price, J. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc010c · Cited by 456
Self-citationA Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment
on behalf of the Rofecoxib Protocol 078 study group, Thal, L. J., Ferris, S. H., Kirby, L., Block, G. A., Lines, C. R., Yuen, E., Assaid, C., Nessly, M. L., Norman, B. A., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300690 · Cited by 402
Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical Dementia
Jicha, G. A., Parisi, J. E., Dickson, D. W., Johnson, K., Cha, R., Ivnik, R. J., Tangalos, E. G., Boeve, B. F., Knopman, D. S., Braak, H., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.674 · Cited by 399
Self-citationAmyloid imaging in mild cognitive impairment subtypes
Wolk, D. A., Price, J. C., Saxton, J. A., Snitz, B. E., James, J. A., López, O. L., Aizenstein, H. J., Cohen, A. D., Weissfeld, L. A., Mathis, C. A., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21598 · Cited by 349
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics
Shaw, L. M. J., Korecka, M., Clark, C. M., Lee, V. M. ‐., & Trojanowski, J. Q. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2176 · Cited by 348
Correlation between rates of brain atrophy and cognitive decline in AD
Fox, N. C., Scahill, R. I., Crum, W. R., & Rossor, M. N. (1999) · Neurology · doi:10.1212/wnl.52.8.1687 · Cited by 342
Feldman, H., Ferris, S. H., Winblad, B. G., Sfikas, N., Mancione, L., He, Y., Tekin, S., Burns, A. S., Cummings, J. L., del Ser, T., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70109-6 · Cited by 340
Visser, P. J., Scheltens, P., Verhey, F. R. J., Schmand, B., Launer, L. J., Jolles, J., & Jonker, C. (1999) · Journal of Neurology · doi:10.1007/s004150050387 · Cited by 319
Prevalence of cognitive impairment: Data from the Indianapolis Study of Health and Aging
Unverzagt, F. W., Gao, S., Baiyewu, O., Ogunniyi, A. O., Gureje, O., Perkins, A., Emsley, C. L., Dickens, J., Evans, R., Musick, B., et al. (2001) · Neurology · doi:10.1212/wnl.57.9.1655 · Cited by 312
Prevalence of mild cognitive impairment: a population-based study in elderly subjects
Hänninen, T., Hallikainen, M., Tuomainen, S., Vanhanen, M., & Soininen, H. (2002) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2002.01225.x · Cited by 300
MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD
Jack, C. R., Slomkowski, M., Gracon, S. I., Hoover, T. M., Felmlee, J. P., Stewart, K., Xu, Y., Shiung, M. S., O’Brien, P. C., Cha, R., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000042480.86872.03 · Cited by 297
Self-citationSafety and efficacy of galantamine in subjects with mild cognitive impairment
Winblad, B. G., Gauthier, S. G., Scinto, L. F. M., Feldman, H., Wilcock, G. K., Truyen, L., Mayorga, A. J., Wang, D., Brashear, H. R., Nye, J. S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000303815.69777.26 · Cited by 269
Synphilin-1 is present in Lewy bodies in Parkinson's disease
Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C. A., & Takahashi, H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4 · Cited by 269
Mild Cognitive Impairment in the General Population: Occurrence and Progression to Alzheimer Disease
Palmer, K., Bäckman, L., Winblad, B. G., & Fratiglioni, L. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181753a64 · Cited by 219
Molano, J. R. V., Boeve, B. F., Ferman, T. J., Smith, G. E., Parisi, J. E., Dickson, D. W., Knopman, D. S., Graff‐Radford, N. R., Geda, Y. E., Lucas, J. A., et al. (2009) · Brain · doi:10.1093/brain/awp280 · Cited by 217
Self-citationLongitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease
Kantarci, K., Weigand, S. D., Petersen, R. C., Boeve, B. F., Knopman, D. S., Gunter, J. L., Reyes, D. A., Shiung, M. S., O’Brien, P. C., Smith, G. E., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.018 · Cited by 213
Self-citationReisberg, ., Ferris, S. H., de Leon, M. J., Franssen, E., Kluger, A., Mir, P., Borenstein, J., GEORGE, A. E., Shulman, E., Steinberg, G., et al. (1988) · Drug Development Research · doi:10.1002/ddr.430150203 · Cited by 203
DONEPEZIL TREATMENT OF PATIENTS WITH MCI: A 48-WEEK RANDOMIZED, PLACEBO- CONTROLLED TRIAL
Crane, P. K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bd6c25 · Cited by 194
Conversion to dementia from mild cognitive disorder
Tschanz, J. T., Welsh-Bohmer, K. A., Lyketsos, C. G., Corcoran, C. M., Green, R. C., Hayden, K. M., Norton, M. C., Zandi, P. P., Toone, L., West, N. A., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000224748.48011.84 · Cited by 181
Mild Cognitive Impairment: Epidemiology and Dementia Risk in an Elderly Italian Population
Ravaglia, G., Forti, P., Montesi, F., Lucicesare, A., Pisacane, N., Rietti, E., Dalmonte, E., Bianchin, M., & Mecocci, P. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01503.x · Cited by 173
An epidemiologic study of mild cognitive impairment in Kolkata, India
Das, S., Bose, P., Biswas, A., Dutt, A., Banerjee, T. K., Hazra, A., Raut, D. K., Chaudhuri, A., & Roy, T. (2007) · Neurology · doi:10.1212/01.wnl.0000264424.76759.e6 · Cited by 168
Mild Cognitive Impairment Is Early-Stage Alzheimer Disease
Morris, J. C. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.15 · Cited by 157
CIND AND MCI IN THE ITALIAN ELDERLY: FREQUENCY, VASCULAR RISK FACTORS, PROGRESSION TO DEMENTIA
Solfrizzi, V., Reiman, E. M., Caselli, R. J., Parigi, A., Capurso, A., & Panza, F. (2007) · Neurology · doi:10.1212/01.wnl.0000295706.28423.65 · Cited by 141
Aggarwal, N. T., Wilson, R. S., Beck, T. L., Bienias, J. L., Berry‐Kravis, E., & Bennett, D. A. (2005) · Neurocase · doi:10.1080/13554790490903038 · Cited by 88
Mild Cognitive Impairment Should Be Considered for DSM-V
Petersen, R. C., & O'Brien, J. T. (2006) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706291085 · Cited by 72
Self-citationRoberts, J. S., Uhlmann, W. R., Petersen, R. C., Karlawish, J. H., & Green, R. C. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.07.131 · Cited by 2
Self-citationO3‐05‐07: Multidimensional biomarker‐based diagnosis of early Alzheimer's disease
Ewers, M., Bokde, A. L. W., Walsh, C., Hampel, H. J., & Initiative, A. D. N. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.463 · Cited by 1
Research works printed but not linked: 2
- [4]Petersen RC Petersen RC Conceptual Overview Mild Cognitive Impairment: Aging to Alzheimer’s Disease New York Oxford University Press, Inc 2003 1 14
- [27]Roberts R Geda Y Knopman D Men are More Likely to Have Mild Cognitive Impairment Than Women: The Mayo Clinic Study of Aging Neurology 2008 abstract (In press)
Cited by
Sorted by citations
Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams‐Gray, C. H., et al. (2012) · Movement Disorders · doi:10.1002/mds.24893 · Cited by 2,609
Self-citationMild cognitive impairment: a concept in evolution
Petersen, R. C., Caracciolo, B., Brayne, C., Gauthier, S., Jelic, V., & Fratiglioni, L. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12190 · Cited by 1,694
Self-citationAlzheimer’s Disease: The Challenge of the Second Century
Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424
Petersen, R. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp0910237 · Cited by 1,289
Self-citationClassifying neurocognitive disorders: the DSM-5 approach
Sachdev, P. S., Blacker, D., Blazer, D. G., Ganguli, M., Jeste, D. V., Paulsen, J. S., & Petersen, R. C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.181 · Cited by 1,116
Self-citation
Metadata
- Authors
- Petersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., Smith, G. E., & Jack, C. R.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2009-12-01
- Volume
- 66
- Issue
- 12
- Pages
- 1447-55
- ISSN
- 0003-9942 (ISSN-L)
- PMC
- PMC3081688
- OpenAlex
- W1972982304
- Cited by
- 1,447
- References
- 59
- Citations by year
- 2026: 54 · 2025: 74 · 2024: 71 · 2023: 72 · 2022: 93 · 2021: 116 · 2020: 85 · 2019: 89 · 2018: 96 · 2017: 72 · 2016: 98 · 2015: 104 · 2014: 89 · 2013: 102 · 2012: 97
- FWCI
- 46.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u01ag024904-10)
- National Institute on Aging (U01-AG-024904, R01AG11378, P50‐AG16574, U01AG06786, U01AG006786, R01AG011378, U19AG010483, P50AG016574)
- National Institute of Mental Health (K01-MH68351, K01MH068351)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- mild cognitive impairment, Alzheimer's disease, dementia, biomarkers, neuroimaging, neuropathology, disease mechanisms, clinical trials
- MeSH terms
- Alzheimer Disease, Clinical Trials as Topic, Cognition Disorders, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
